Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Glutamine × Gastrointestinal × Clear all

Phase

Phase NA 2 Phase 3 2 Phase 2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Malnutrition 1 Digestive System Neoplasms 1

Interventions

Oxaliplatin 21 Capecitabine 19 Fluorouracil 16 Bevacizumab 15 Esomeprazole 11 Sorafenib 10 Irinotecan 9 Leucovorin 8 Radiofrequency Ablation 7 Propofol 7 Bismuth 7 Morphine 6 Amoxicillin 6 lenvatinib 5 gadolinium ethoxybenzyl DTPA 5 Tetracycline 5 Sevoflurane 5 S 1 (combination) 5 Gemcitabine 5 Folfox protocol 5 Drug Therapy 5 Control Groups 5 sodium glycididazole 4 fish oil triglycerides 4 ferric carboxymaltose 4 Ribavirin 4 Hepatectomy 4 HMPL-013 4 Furazolidone 4 Enoxaparin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01552291 2018-02-13

Glutaminprojec

Insel Gruppe AG, University Hospital Bern

Phase 4 Completed

Gastrointestinal

Digestive System Neoplasms, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon ⚡